Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · November 25, 2016

Rivaroxaban in Two Treatment Strategies Reduces Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting

Circulation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy
Circulation 2016 Nov 14;[EPub Ahead of Print], CM Gibson, DS Pinto, G Chi, D Arbetter, M Yee, R Mehran, C Bode, J Halperin, FWA Verheugt, P Wildgoose, P Burton, M van Eickels, S Korjian, Y Daaboul, P Jain, GYH Lip, M Cohen, ED Peterson, KAA Fox

Further Reading